Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|June 29, 2007
Targeting vessel abnormalization in cancerKen Garber
Nature Biotechnology|September 11, 2010
Oncology's energetic pipelineKen Garber
Journal of the National Cancer Institute|May 13, 2010
ALK, lung cancer, and personalized therapy: portent of the future?Ken Garber
Journal of the National Cancer Institute|February 27, 2009
Targeting mTOR: something old, something newKen Garber
Nature Biotechnology|August 10, 2013
Melanoma combination therapies ward off tumor resistanceKen Garber
Nature Biotechnology|June 12, 2013
Inducing translationKen Garber
Nature Reviews. Drug Discovery|November 1, 2014
Bispecific antibodies rise againKen Garber
Nature|May 7, 2025
How protein-slayer drugs could beat some of the cruellest cancersKen Garber
Journal of the National Cancer Institute|May 15, 2008
Hedgehog drugs begin to show resultsKen Garber
Nature|March 28, 2014
Immunology: A tolerant approachKen Garber
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|June 29, 2007
Targeting vessel abnormalization in cancerKen Garber
Nature Biotechnology|September 11, 2010
Oncology's energetic pipelineKen Garber
Journal of the National Cancer Institute|May 13, 2010
ALK, lung cancer, and personalized therapy: portent of the future?Ken Garber
Journal of the National Cancer Institute|February 27, 2009
Targeting mTOR: something old, something newKen Garber
Nature Biotechnology|August 10, 2013
Melanoma combination therapies ward off tumor resistanceKen Garber
Nature Biotechnology|June 12, 2013
Inducing translationKen Garber
Nature Reviews. Drug Discovery|November 1, 2014
Bispecific antibodies rise againKen Garber
Nature|May 7, 2025
How protein-slayer drugs could beat some of the cruellest cancersKen Garber
Journal of the National Cancer Institute|May 15, 2008
Hedgehog drugs begin to show resultsKen Garber
Nature|March 28, 2014
Immunology: A tolerant approachKen Garber
Pageof 20